Home > Qtrly Results > BIOCON

BIOCON
Quarterly Results Analysis [Mar2024]

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Quarterly Results

Consolidated Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Revenues ₹3,917 Cr ₹3,954 Cr ₹3,462 Cr ₹3,423 Cr ₹3,774 Cr ₹2,941 Cr ₹2,320 Cr ₹2,140 Cr
Expenses ₹3,001 Cr ₹3,027 Cr ₹2,721 Cr ₹2,708 Cr ₹2,777 Cr ₹2,297 Cr ₹1,849 Cr ₹1,740 Cr
Operating Income ₹916 Cr ₹927 Cr ₹742 Cr ₹714 Cr ₹997 Cr ₹644 Cr ₹471 Cr ₹399 Cr
Other Income ₹49 Cr ₹566 Cr ₹158 Cr ₹94 Cr ₹155 Cr ₹79 Cr ₹65 Cr ₹78 Cr
Interest ₹227 Cr ₹267 Cr ₹248 Cr ₹233 Cr ₹249 Cr ₹120 Cr ₹30 Cr ₹20 Cr
Depreciation ₹407 Cr ₹415 Cr ₹389 Cr ₹358 Cr ₹364 Cr ₹301 Cr ₹231 Cr ₹218 Cr
Profit Before Tax ₹322 Cr ₹832 Cr ₹239 Cr ₹217 Cr ₹537 Cr ₹30 Cr ₹257 Cr ₹240 Cr
Profit After Tax ₹226 Cr ₹777 Cr ₹197 Cr ₹182 Cr ₹455 Cr ₹35 Cr ₹110 Cr ₹210 Cr
EPS ₹1.13 ₹5.50 ₹1.05 ₹0.84 ₹2.61 ₹-0.35 ₹0.39 ₹1.20
Industry Peers & Returns1W1M1Y
BIOCON 4.8% 10.3% 31.3%
SUN PHARMACEUTICAL INDUSTRIES -2.9% 0% 59.6%
CIPLA 5.8% 6.2% 60.9%
DR REDDYS LABORATORIES 0.9% -1.5% 32.2%
ZYDUS LIFESCIENCES -2.6% 15.3% 114.4%
DIVIS LABORATORIES 5% 8% 25.9%
MANKIND PHARMA -2.3% -14% 57.7%
TORRENT PHARMACEUTICALS -3.4% -2.7% 61.2%
LUPIN -2.8% 2.1% 110.5%

BIOCON Quarterly Revenues

Revenues
Q-o-Q

-0.93 %

Y-o-Y

3.79 %

Quarters Revenues % Change
Mar2024 ₹3,917 Cr
-0.93
Dec2023 ₹3,954 Cr
14.19
Sep2023 ₹3,462 Cr
1.16
Jun2023 ₹3,423 Cr
-9.31
Mar2023 ₹3,774 Cr
28.32
Dec2022 ₹2,941 Cr
26.79
Sep2022 ₹2,320 Cr
8.42
Jun2022 ₹2,140 Cr -

BIOCON Quarterly Operating Profit

Operating Profit
Q-o-Q

-1.18 %

Y-o-Y

-8.16 %

Quarters Operating Profit % Change
Mar2024 ₹916 Cr
-1.18
Dec2023 ₹927 Cr
24.97
Sep2023 ₹742 Cr
3.81
Jun2023 ₹714 Cr
-28.37
Mar2023 ₹997 Cr
54.79
Dec2022 ₹644 Cr
36.88
Sep2022 ₹471 Cr
17.85
Jun2022 ₹399 Cr -
Operating Margins
Q-o-Q

-0.26 %

Y-o-Y

-11.54 %

Quarters Operating Margin% % Change
Mar2024 23.38%
-0.26
Dec2023 23.44%
9.43
Sep2023 21.42%
2.64
Jun2023 20.87%
-21.04
Mar2023 26.43%
20.63
Dec2022 21.91%
7.98
Sep2022 20.29%
8.68
Jun2022 18.67% -

BIOCON Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-70.98 %

Y-o-Y

-50.37 %

Quarters Profit After Tax % Change
Mar2024 ₹226 Cr
-70.98
Dec2023 ₹777 Cr
294.82
Sep2023 ₹197 Cr
8.13
Jun2023 ₹182 Cr
-59.94
Mar2023 ₹455 Cr
1,202.58
Dec2022 ₹35 Cr
-68.30
Sep2022 ₹110 Cr
-47.67
Jun2022 ₹210 Cr -
PAT Margins
Q-o-Q

-70.70 %

Y-o-Y

-52.20 %

Quarters PAT Margin(%) % Change
Mar2024 5.76 %
-70.70
Dec2023 19.66 %
245.52
Sep2023 5.69 %
6.95
Jun2023 5.32 %
-55.85
Mar2023 12.05 %
912.61
Dec2022 1.19 %
-74.95
Sep2022 4.75 %
-51.68
Jun2022 9.83 % -

BIOCON Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-79.45 %

Y-o-Y

-56.70 %

Quarters EPS % Change
Mar2024 ₹1.13
-79.45
Dec2023 ₹5.5
423.81
Sep2023 ₹1.05
25.00
Jun2023 ₹0.84
-67.82
Mar2023 ₹2.61
Positive
Dec2022 ₹-0.35
Negative
Sep2022 ₹0.39
-67.50
Jun2022 ₹1.2 -

You may also like the below Video Courses